Pomdoctor Limited (POM)
NasdaqGM: POM
· Real-Time Price · USD
1.02
+0.05 (5.15%)
At close: Aug 13, 2026, 3:59 PM
0.98
-3.92%
After-hours: 7:48 PM
Pomdoctor Limited (POM) Stock Price, Analysis & Data
5.15% (1D)
| Bid | 0.11 |
| Market Cap | 7.6M |
| Revenue (ttm) | 399.91M |
| Net Income (ttm) | -212.58M |
| Beta | n/a |
| EPS (ttm) | -6.29 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | -0.12 |
| P/S (ttm) | 0.02 |
| Earnings Date | n/a |
| Ask | 1.01 |
| Volume | 35,876 |
| Avg. Volume (20D) | 94,611 |
| Open | 0.90 |
| Previous Close | 0.97 |
| Day's Range | 0.86 - 1.02 |
| 52-Week Range | 0.50 - 115.74 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About POM
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply c...
Industry Pharmaceutical Retailers
Sector Healthcare
IPO Date Oct 8, 2025
Employees 165
Stock Exchange NasdaqGM
Ticker Symbol POM
Website https://www.7lk.com
Financial Performance
In 2025, Pomdoctor's revenue was 399.91M, an increase of 16.74% compared to the previous year's 342.56M. Earnings were -212.58M, an increase of 48.28%.
Financial Statements